Exposure to Toxic Agents: The Heme Biosynthetic Pathway and Hemoproteins as Indicator

References

• Walman S. A., Sinacore M. S., Lewicki J. A., Chang L. Y., Murad F. Selective activation of particulate guanylate cyclase by a specific class of porphyrins. J. Biol. Chem. 1984; 259: 4038
   PubMed Web of Science ®Google Scholar
• Graf H., Ruf H. H., Ullrich V. Prostacyclin synthase, a cytochrome P450 enzyme. Angew. Chem. Int. Ed. Engl 1983; 22: 487
   Web of Science ®Google Scholar
• Kappas A., Sassa S., Anderson K. E. The porphyrias. The Metabolic Basis of Inherited Disease, B.-J. Stanbury, J. B. Wyngaarden, D. S. Fredrickson. McGraw-Hill, New York 1982; 1301
   Google Scholar
• Tyrrell D. L. J., Marks G. S. Drug-induced porphyrin biosynthesis. V. Effect of protohemin on the transcriptional and post-transcriptional phases of β-aminolevulinic acid synthetase induction. Biochem. Pharmacol. 1972; 21: 2077
   PubMed Web of Science ®Google Scholar
• Yamamoto M., Hayashi N., Kikuchi G. Evidence for the transcriptional inhibition by heme of the synthesis of β-aminolevulinate synthase in rat liver. Biochem. Biophys. Res. Commun. 1982; 105(3)985
   PubMed Web of Science ®Google Scholar
• Hayashi N., Watanabe N., Kikuchi G. Inhibition by hemin of in vitro translocation of chicken liver β-aminolevulinic synthase into mitochondria. Biochem. Biophys. Res. Commun. 1983; 115(2)155
   Web of Science ®Google Scholar
• Tait G. H. Heme and hemoproteins. Handbook of Experimental Pharmacology, F. De Matteis, W. N. Aldridge. Springer-Verlag, Berlin 1978; Vol. 44: 1
   Google Scholar
• Marks G. S., Follows S. B., Zelt D. T., Cole S. P. C. Patterns of porphyrin accumulation in response to chemicals in chick embryo liver cells. Can. J. Physiol. Pharmacol. 1983; 61(6)546
   PubMed Web of Science ®Google Scholar
• Zelt D. T., Owen J. A., Marks G. S. Second derivative high performance liquid chromatographic fluorometric detection of porphyrins in chick embryo liver cell culture medium. J. Chromatogr. 1980; 189: 209
   PubMed Web of Science ®Google Scholar
• De Verneuil H., Sassa S., Kappas A. Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Biochem. J. 1983; 214: 145
   PubMed Web of Science ®Google Scholar
• Lim C. K., Rideout J. M., Wright D. J. High-performance liquid chromatography of naturally occurring 8-, 7-, 6-, 5- and 4-carboxylic porphyrin isomers. J. Chromatogr. 1983; 282: 629
   PubMed Web of Science ®Google Scholar
• Sassa S. Toxic effects of lead, with particular reference to porphyrin and heme metabolism. Handbook of Experimental Pharmacology, F. De Matteis, W. N. Aldridge. Springer-Verlag, Berlin 1978; Vol. 44: 333
   Google Scholar
• Hodson P. V., Blunt B. R., Spry D. J., Austen K. Evaluation of erythrocyte β-amino levu-linic acid dehydratase activity as a short-term indicator in fish of a harmful exposure to lead. J. Fish. Res. Board Can. 1977; 34(4)501
   Google Scholar
• Hodson P. V. β-Amino levulinic acid dehydratase activity of fish blood as an indicator of a harmful exposure to lead. J. Fish. Res. Board Can. 1976; 33(2)268
   Google Scholar
• Hutton M. The effects of environmental lead exposure and in vitro zinc on tissue β-aminolevulinic acid dehydratase in urban pigeons. Comp. Biochem. Physiol. 1983; 74C(2)441
   Google Scholar
• Lamola A. A., Yamane T. Zinc protoporphyrin in the erythrocytes of patients with lead intoxication and iron deficiency anemia. Science 1974; 186: 936
   PubMed Web of Science ®Google Scholar
• Lamola A. A., Piomelli S., Poh-Fitzpatrick M., Yamane T., Harbo L. Erythropoietic protoporphyria and Pb intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin. J. Clin. Invest. 1975; 56: 1528
   PubMed Web of Science ®Google Scholar
• Valciukas J. A., Lilis R., Fischbein A., Selikoff I. J. Central nervous system dysfunction due to lead exposure. Science 1978; 201: 465
   PubMed Web of Science ®Google Scholar
• Silbergeld E. K. Current status of neurotoxicology, basic and applied. Trends Neurosci. 1982; 5(9)291
   Web of Science ®Google Scholar
• Lamola A. A., Joselow M., Yamane T. Zinc protoporphyrin (ZPP): a simple, sensitive, fluorometric screening test for lead poisoning. Clin. Chem. 1975; 21(1)93
   PubMed Web of Science ®Google Scholar
• Haeger-Aronsen B. Why is the patient with lead intoxication not light sensitive?. Acta Derm. Ve-nereol. Suppl. 1982; 100: 67
   PubMedGoogle Scholar
• Piper W. N., Tephly T. R. Differential inhibition of erythrocyte and hepatic uroporphyrinogen I synthetase activity by lead. Life Sci. 1974; 14: 873
   PubMed Web of Science ®Google Scholar
• Fischbein A., Wallace J., Anderson K. E., Sassa S., Kon S., Rohl A. N., Kappas A. Lead poisoning in an art conservator. JAMA 1982; 247: 2007
   PubMed Web of Science ®Google Scholar
• Fowler B. A., Mahaffey K. R. Interactions among lead, cadmium, and arsenic in relation to porphyrin excretion patterns. Environ. Health Perspect. 1978; 25: 87
   PubMed Web of Science ®Google Scholar
• Martinez G., Cebrian M., Chamorro G., Jauge P. Urinary uroporphyrin as an indicator of arsenic exposure in rats. Proc. West. Pharmacol. Soc. 1983; 26: 171
   PubMedGoogle Scholar
• Eiseman J. L., Alvares A. P. Alterations induced in heme pathway enzymes and monooxygen-ases by gold. Mol. Pharmacol. 1978; 14: 1176
   PubMed Web of Science ®Google Scholar
• Eiseman J. L., Alvares A. P. Heme metabolism in the fetoplacental unit and neonatal livers during lactation: effect of gold sodium thiomalate. J. Pharmacol. Exp. Ther. 1980; 214: 250
   PubMed Web of Science ®Google Scholar
• Woods J. S., Fowler B. A. Renal porphyrinuria during chronic methyl mercury exposure. J. Lab. Clin. Med. 1977; 90: 266
   PubMed Web of Science ®Google Scholar
• Woods J. S., Kardish R., Fowler B. A. Studies on the action of porphyrinogenic trace metals on the activity of hepatic uroporphyrinogen decarboxylase. Biochem. Biophys. Res. Commun. 1981; 103: 264
   PubMed Web of Science ®Google Scholar
• Maines M. D., Chung A., Kutty R. K. The inhibition of testicular heme oxygenase activity by cadmium. J. Biol. Cnem. 1982; 257: 14116
   Google Scholar
• Woods J. S., Carver G. T., Fowler B. A. Altered regulation of hepatic metabolism by indium chloride. Toxicol. Appl. Pharmacol. 1979; 49: 455
   PubMed Web of Science ®Google Scholar
• Woods J. S., Fowler B. A. Selective inhibition of β-aminolevulinic acid dehydratase by indium chloride in rat kidney: biochemical and ultrastructural studies. Exp. Mol. Pathol 1982; 36: 306
   PubMed Web of Science ®Google Scholar
• Kappas A., Maines M. D. Tin: a potent inducer of heme oxygenase in kidney. Science 1976; 192: 60
   PubMed Web of Science ®Google Scholar
• Tephly T. R., Hibbeln P. The effect of cobalt chloride administration on the synthesis of hepatic microsomal cytochrome P-450. Biochem. Biophys. Res. Commun. 1971; 42: 589
   PubMed Web of Science ®Google Scholar
• Yasukochi Y., Nakamura M., Minakami S. Effect of cobalt on the synthesis and degradation of hepatic catalase in vivo. Biochem. J. 1974; 144: 455
   PubMed Web of Science ®Google Scholar
• Tephly T. R., Webb C., Trussler P., Kniffen F., Hasegawa E., Piper W. The regulation of heme synthesis related to drug metabolism. Drug Metab. Dispos. 1973; 1: 259
   PubMed Web of Science ®Google Scholar
• De Matteis F., Unseld A. Increased liver haem degradation caused by foreign chemicals: a comparison of the effects of 2-ally-2-isopropylacetamide and cobaltous chloride. Biochem. Soc. Trans. 1976; 4: 205
   PubMed Web of Science ®Google Scholar
• Maines M. D., Kappas A. Trace metal regulation of heme and hemoprotein oxidation. Hoppe-Seyler's Z. Physiol. Cnem. 1976; 357: 1038
   Google Scholar
• Nakamura M., Yasukochi Y., Minakami S. Effect of cobalt on heme biosynthesis in rat liver and spleen. J. Biochem. (Tokyo) 1975; 78: 373
   PubMed Web of Science ®Google Scholar
• De Matteis F., Gibbs A. H. The effect of cobaltous chloride on liver haem metabolism in the rat. Ann. Clin. Res. 1976; 8: 193, Suppl. 17
   PubMedGoogle Scholar
• De Matteis F., Gibbs A. H. Inhibition of haem synthesis caused by cobalt in rat liver. Biochem. J. 1977; 162: 213
   PubMed Web of Science ®Google Scholar
• Sinclair P., Gibbs A. H., Sinclair J. F., De Matteis F. Formation of cobalt protoporphyrin in the liver of rats. Biochem. J. 1979; 178: 529
   PubMed Web of Science ®Google Scholar
• Watkins S., Baron J., Tephly T. R. Identification of cobalt protoporphyrin IX formationin vivo following cobalt administration to rats. Biochem. Pharmacol. 1980; 29: 2319
   PubMed Web of Science ®Google Scholar
• Igarashi J., Hayashi N., Kikuchi G. Effects of administration of cobalt protoporphyrin on β-aminolevulinate synthase in rat liver. J. Biochem. (Tokyo) 1978; 84: 997
   PubMed Web of Science ®Google Scholar
• Sinclair P. R., Sinclair J. F., Bonkowsky H. L., Gibbs A. H., De Matteis F. Formation of cobalt protoporphyrin by chicken hepatocytes in culture. Biochem. Pharmacol. 1982; 31: 993
   PubMed Web of Science ®Google Scholar
• Maines M. D., Kappas A. Metals as regulators of heme metabolism. Science 1977; 198: 1215
   PubMed Web of Science ®Google Scholar
• Maines M. D., Kappas A. Regulation of cytochrome P-450-dependent microsomal drug-metabolizing enzymes by nickel, cobalt, and iron. Clin. Pharmacol. Ther. 1977; 22: 780
   PubMed Web of Science ®Google Scholar
• Tephly T. R., Coffman B. L., Abou Zeit-Har M. S., Sedman R., West E., Simon I. Toxic effects of metals on the synthesis and disposition of heme. Advances in Pharmacology and Therapeutics II, H. Yoshida, Y. Hagihara, S. Ebashi. Pergamon Press, Oxford 1982; Vol. 5: 139
   Google Scholar
• Tephly T. R., Wagner G., Sedman R., Piper W. Effects of metals on heme biosynthesis and metabolism. Fed. Proc. 1978; 37: 35
   PubMedGoogle Scholar
• Tephly T. R. Inhibition of liver hemoprotein synthesis. Handbook of Experimental Pharmacology, F. De Matteis, W. N. Aldridge. Springer-Verlag, Berlin 1978; Vol. 44: 81
   Google Scholar
• Tenhunen R., Savolainen H., Jäppinen P. Changes in haem synthesis associated with occupational exposure to organic and inorganic sulphides. Clin. Sci. 1983; 64: 187
   Web of Science ®Google Scholar
• Dogramaci I., Wray J. D., Ergene T., Sezer V., Muftu Y. Porphyria turcica. Turk. J. Pediatr. 1962; 4: 138
   Google Scholar
• Dogramaci I. Porphyrias and porphyrin metabolism, with special reference to porphyria in childhood. Adv. Pediatr. 1964; 13: 11
   PubMedGoogle Scholar
• Peters H. A., Johnson S. A. M., Cam S., Oral S., Muftu Y., Ergene T. Hexachlorobenzene-induced porphyria: effect of chelation on the disease, porphyrin and metal metabolism. Am. J. Med. 1966; 251: 314
   Google Scholar
• Schmid R. Cutaneous porphyria in Turkey. N. Engl. J. Med. 1960; 263: 397
   PubMed Web of Science ®Google Scholar
• Cam C., Nigogosyan G. Acquired toxic porphyria cutanea tarda due to hexachlorobenzene. JAMA 1963; 183: 88
   PubMed Web of Science ®Google Scholar
• Courtney K. D. Hexachlorobenzene (HCB): a review. Environ. Res. 1979; 20: 225
   PubMed Web of Science ®Google Scholar
• Ockner R. K., Schmid R. Acquired porphyria in man and rat due to hexachlorobenzene intoxication. Nature (London) 1961; 189: 499
   PubMed Web of Science ®Google Scholar
• De Matteis F., Prior B. E., Rimington C. Nervous and biochemical disturbances following hexachlorobenzene intoxication. Nature (London) 1961; 191: 363
   PubMed Web of Science ®Google Scholar
• Elder G. H. Porphyria caused by hexachlorobenzene and other polyhalogenated aromatic hydrocarbons. Handbook of Experimental Pharmacology, F. De Matteis, W. N. Aldridge. Springer-Verlag, Berlin 1978; Vol. 44: 157
   Google Scholar
• Jackson A. H., Sancovich H. A., Ferramola A. M., Evans N., Games D. E., Matlin S. A., Elder G. H., Smith S. G. Macrocyclic intermediates in the biosynthesis of porphyrins. Philos. Trans. R. Soc. London 1976; 273: 191
   PubMed Web of Science ®Google Scholar
• San Martin de Viale L. C., Rios C., Del De Molina M., Wainstock De Calmanovici R., Tomio J. M. Experimental porphyria produced in rats by hexachlorobenzene. IV. Studies on the stepwise decarboxylation of uroporphyrinogen and phyriaporphyrinogenin vivo andin vitro in several tissues. Porphyrins in Human Diseases, M. Doss. S. Karger, Basel 1976; 445
   Google Scholar
• Cripps D. J., Goeman A., Peters H. A. Porphyria turcica. Twenty years after hexachlorobenzene intoxication. Arch. Dermatol. 1980; 116: 46
   PubMedGoogle Scholar
• Koss G., Seubert S., Seubert A., Seidel J., Koransky W., Ippen H. Studies on the toxicology of hexachlorobenzene. Arch. Toxicol. 1983; 52: 13
   PubMed Web of Science ®Google Scholar
• Koss G., Seubert S., Seubert A., Koransky W., Ippen H. Studies on the toxicology of hexachlorobenzene. Arch. Toxicol. 1978; 40: 285
   PubMed Web of Science ®Google Scholar
• Koss G., Koransky W., Steinbach K. Studies on the toxicology of hexachlorobenzene. Arch. Toxicol. 1979; 42: 19
   PubMed Web of Science ®Google Scholar
• Rizzardini M., Smith A. G. Sex differences in the metabolism of hexachlorobenzene by rats and the development of porphyria in females. Biochem. Pharmacol. 1982; 31: 3543
   PubMed Web of Science ®Google Scholar
• Debets F. M. H., Hamers W. J. H. M. B, Strik J. J. T. W. A. Metabolism as a prerequisite for the porphyrinogenic action of polyhalogenated aromatics, with special reference to hexachlorobenzene and polybrominated biphenyls (Firemaster BP-6). Int. J. Biochem. 1980; 12: 1019
   PubMedGoogle Scholar
• Debets F. M. H., Reinders J. H., Debets A. J. M., Lössbroek T. G., Strik J. J. T. W. A, Koss G. Biotransformation and porphyrinogenic action of hexachlorobenzene and its metabolites in a primary liver cell culture. Toxicology 1981; 19: 185
   PubMed Web of Science ®Google Scholar
• Smith A. G., Cabral J. R. P., De Matteis F. A difference between two strains of rats in their liver non-haem iron content and in their response to the porphyrogenic effect of hexachlorobenzene. Chem. Biol Interact. 1979; 27: 353
   PubMed Web of Science ®Google Scholar
• Miranda C. L., Wang J.-L., Henderson M. C., Carpenter H. M., Nakaue H. S., Buhler D. R. Studies on the porphyrinogenic action of 1,2,4-trichlorobenzene in birds. Toxicology 1983; 28: 83
   PubMed Web of Science ®Google Scholar
• Rimington C., Ziegler G. Experimental porphyria in rats induced by chlorinated benzenes. Biochem. Pharmacol. 1963; 12: 1387
   PubMed Web of Science ®Google Scholar
• Carlson G. P. Chlorinated benzene induction of hepatic porphyria. Experientia 1977; 33: 1627
   PubMedGoogle Scholar
• Carlson G. P. Brominated benzene induction of hepatic porphyria. Experientia 1979; 35(4)513
   PubMedGoogle Scholar
• Mendoza C. E., Shields J. B., Laver G. W. Comparison of the porphyrinogenic activity of hexabromobenzene and hexachlorobenzene in primiparous Wistar rats. Bull. Environ. Contam. Toxicol. 1979; 21: 358
   PubMed Web of Science ®Google Scholar
• Smith A. G., Francis J. E. Relative abilities on a molar basis of hexafluoro-, hexachloro-and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats. Res. Commun. Chem. Pathol. Pharmacol. 1980; 28: 377
   PubMedGoogle Scholar
• Hay A. The chemical scythe. Lesson of 2,4,5-Tand Dioxin. Plenum Press, New York 1982; 1
   Google Scholar
• Bleiberg J., Wallen M., Brodkin R., Appelbaum I. L. Industrially-acquired porphyria. Arch. Dermatol. 1964; 89: 793
   PubMed Web of Science ®Google Scholar
• Jirasek L., Kalensky J., Kubec K. Acne chlorina, porphyria cutanea tards pri vyrobe herbicid. Ceska Dermatol. 1973; 48: 306
   PubMedGoogle Scholar
• Riedel D. A review of the toxicology of the herbicide 2,4-D (2,4-dichlorophenoxyacetic acid). Chron. Dis. Can. 1983; 4(1)4
   Google Scholar
• Poland A., Knutson J. C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 1982; 22: 517
   PubMed Web of Science ®Google Scholar
• Crow K. D. Chloracne. Trans. St. John's Hosp. Dermatol. Soc. 1970; 56: 79
   PubMedGoogle Scholar
• Poland A., Glover E. 2,3,7,8-Tetrachlorodibenzo-(p)-dioxin: a potent inducer of β-aminolevu-linic acid synthetase. Science 1973; 179: 476
   PubMed Web of Science ®Google Scholar
• Goldstein J. A., Hickman P., Vos J. G. Hepatic porphyria induced by 2,3,7,8-tetrachlorodi-benzo-p-dioxin in the mouse. Res. Commun. Chem. Pathol. Pharmacol. 1973; 6: 919
   PubMedGoogle Scholar
• Cantoni L., Salmona M., Rizzardini M. Porphyrogenic effect of chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats. Dose-effect relationship following urinary excretion of porphyrins. Toxicol. Appl. Pharmacol. 1981; 57: 156
   PubMed Web of Science ®Google Scholar
• Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Dittenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D., Hummel R. A., Humiston C. G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 1978; 46: 279
   PubMed Web of Science ®Google Scholar
• Jones K. G., Sweeney G. D. Association between induction of aryl hydrocarbon hydroxylase and depression of uroporphyrinogen decarboxylase activity. Res. Commun. Chem. Pathol. Pharmacol. 1977; 17: 631
   PubMedGoogle Scholar
• Elder G. H., Sheppard D. M. Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene. Biochem. Biophys. Res. Commun. 1982; 109: 113
   PubMed Web of Science ®Google Scholar
• Cantoni L., Fiume D. D., Rizzardini M., Ruggieri R. In vitro inhibitory effect on porphyrinogen carboxylase of liver extracts from TCDD treated mice. Toxicol. Lett. 1984; 20: 211
   PubMed Web of Science ®Google Scholar
• Vos J. G., Koeman J. H. Comparative toxicologic study with polychlorinated biphenyls in chicken with special reference to porphyria, edema formation, liver necrosis, and tissue residues. Toxicol. Appl. Pharmacol. 1970; 17: 656
   PubMed Web of Science ®Google Scholar
• Vos J. G., Strik J. J. T. W. A, Van Holsteyn C. W. M., Pennings J. H. Polychlorinated biphenyls as inducers of hepatic porphyria in Japanese quail, with special reference to β-aminolevu-linic acid synthetase activity, fluorescence, and residues in the liver. Toxicol. Appl. Pharmacol. 1971; 20: 232
   PubMed Web of Science ®Google Scholar
• Vos J. G., Notenboom-Ram E. Comparative toxicity study of 2,4,5,2′,4′,5′-hexachlorobi-phenyl and a polychlorinated biphenyl mixture in rabbits. Toxicol. Appl. Pharmacol. 1972; 23: 563
   PubMed Web of Science ®Google Scholar
• Goldstein J. A., Hickman P., Burse V. W., Bergman H. A comparative study of two polychlorinated biphenyl mixtures (Aroclors 1242 and 1016) containing 42% chlorine on induction of hepatic porphyria and drug metabolizing enzymes. Toxicol. Appl. Pharmacol. 1975; 32: 461
   PubMed Web of Science ®Google Scholar
• Goldstein J. A., Hickman P., Jue D. L. Experimental hepatic porphyria induced by polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 1974; 27: 437
   PubMed Web of Science ®Google Scholar
• Kimbrough R. D. The toxicity of polychlorinated polycyclic compounds and related chemicals. CRC Crit. Rev. Toxicol. 1974; 2: 445
   PubMedGoogle Scholar
• Chang K.-J., Lu F.-J., Tung T.-C. Studies on patients with polychlorinated biphenyl poisoning. Res. Commun. Chem. Pathol. Pharmacol. 1980; 30: 547
   PubMedGoogle Scholar
• Kay K. Polybrominated biphenyls (PBB) environmental contamination in Michigan, 1973-1976. Environ. Res. 1977; 13: 74
   PubMed Web of Science ®Google Scholar
• Strik J. J. T. W. A, Doss M., Schraa G., Robertson L. W., Tiepermann R., Harmsen E. G. M. Coproporphyrinuria and chronic hepatic porphyria type A found in farm families from Michigan (USA) exposed to polybrominated biphenyls (PBB). Chemical Porphyria in Man, J. J. T. W. A Strik, J. H. Koeman. Elsevier, Amsterdam 1979; 29
   Google Scholar
• Gupta B. N., McConnell E. E., Goldstein J. A., Harris M. W., Moore J. A. Effects of a polybrominated biphenyl mixture in the rat and mouse. Toxicol. Appl. Pharmacol. 1983; 68: 1
   PubMed Web of Science ®Google Scholar
• Sinclair P., Granick S. Uroporphyrin formation induced by chlorinated hydrocarbons (Lindane, polychlorinated biphenyls, tetrachlorodibenzo-p-dioxin). Requirements for endogenous iron, protein synthesis and drug metabolizing activity. Biochem. Biophys. Res. Commun. 1974; 61: 124
   PubMed Web of Science ®Google Scholar
• Kawanishi S., Mizutani T., Sano S. Induction of porphyrin synthesis in chick embryo liver cell culture by synthetic polychlorobiphenyl isomers. Biochim. Biophys. Acta 1978; 540: 83
   PubMed Web of Science ®Google Scholar
• Marks G. S., Zelt D. T., Cole S. P. C. Alterations in the heme biosynthetic pathway as an index of exposure to toxins. Can. J. Physiol. Pharmacol. 1982; 60: 1017
   PubMed Web of Science ®Google Scholar
• Marks G. S. The effects of chemicals on hepatic heme biosynthesis. Handbook of Experimental Pharmacology, F. De Matteis, W. N. Aldridge. Springer-Verlag, Berlin 1978; Vol. 44: 201
   Google Scholar
• Swain M. G., Follows S. B., Marks G. S. Inhibition of uroporphyrinogen decarboxylase by 3,3′,4,4′-tetrachlorobiphenyl in chick embryo liver cell culture, Can. J. Physiol. Pharmacol. 1983; 61: 105
   Web of Science ®Google Scholar
• De Verneuil H., Grandchamp B., Nordmann Y. Some kinetic properties of human red cell uroporphyrinogen decarboxylase. Biochim. Biophys. Acta 1980; 611: 174
   PubMed Web of Science ®Google Scholar
• Smith A. G., Francis J. E. Investigations of rat liver uroporphyrinogen decarboxylase. Biochem. J. 1981; 195: 241
   PubMed Web of Science ®Google Scholar
• Kawanishi S., Seki Y., Sano S. Polychlorobiphenyls that induce β-aminolevulinic acid synthetase inhibit uroporphyrinogen decarboxylase in cultured chick embryo liver cells. FEBS Lett. 1981; 129: 93
   PubMed Web of Science ®Google Scholar
• Kawanishi S., Seki Y., Sano S. Uroporphyrinogen decarboxylase. J. Biol. Chem. 1983; 258: 4285
   PubMed Web of Science ®Google Scholar
• Slotsve M., Owen J., Marks G. S. 1984, unpublished observations
   Google Scholar
• Sinclair P. R., Bement W. J., Bonkovsky H. L., Sinclair J. F. Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Biochem. J. 1984; 222: 737
   PubMed Web of Science ®Google Scholar
• Centen A. H., Strik J. J. T. W. A, Colombi A. Coproporphyrinuria and chronic hepatic porphyria type A found in people from Seveso (Italy) exposed to 2,3,7,8-tetrachlorodibenzo-(p)-dioxin (TCDD). Chemical Porphyria in Man, J. J. T. W. A Strik, J. H. Koeman. Elsevier, Amsterdam 1979; 75
   Google Scholar
• Strik J. J. T. W. A, Koeman J. H. Chemical Porphyria in Man, J. J. T. W. A Strik, J. H. Koeman. Elsevier, Amsterdam 1979
   Google Scholar
• Doss M., Lange C. E., Veltman G. Toxic porphyrinuria and chronic hepatic porphyria after vinyl chloride exposure in humans. Chemical Porphyria in Man, J. J. T. W. A Strik, J. H. Koeman. Elsevier, Amsterdam 1979; 107
   Google Scholar
• Bleakely P., Nichol A. W., Collins A. G. Diazinon and porphyria cutanea tarda. Med. J. Aust. 1979; 1: 314
   PubMed Web of Science ®Google Scholar
• Bopp C., Kosminsky B. Toxic hepato-cutaneous porphyria (occupational disease). Med. Cutanae Ibero Lat. Am. 1975; 3: 271
   PubMedGoogle Scholar
• Nichol A. W., Elsbury S., Elder G. H., Jackson A. H., Rao K. R. N. Separation of impurities in diazinon preparations and their effects on porphyrin biosynthesis in tissue culture. Biochem. Pharmacol. 1982; 31: 1033
   PubMed Web of Science ®Google Scholar
• Nichol A. W., Elsbury S., Angel L. A., Elder G. H. The site of inhibition of porphyrin biosynthesis by an isomer of diazinon in rats. Biochem. Pharmacol. 1983; 32: 2653
   PubMed Web of Science ®Google Scholar
• De Matteis F., Gibbs A. H., Tephly T. R. Inhibition of protohaem ferro-lyase in experimental porphyria. Biochem. J. 1980; 188: 145
   PubMed Web of Science ®Google Scholar
• Taira M. C., San Martin de Viale L. C. Porphyrinogen carboxylyase from chick embryo liver—in vivo effect of heptachlor and Lindane. Int. J. Biochem. 1980; 12: 1033
   PubMedGoogle Scholar
• De Matteis F. Drugs and porphyria. S. Afr. Med. J. 1971; 45: 126
   PubMedGoogle Scholar
• Marks G. S., Hunter E. G., Terner U. K., Schneck D. Studies of the relationship between chemical structure and porphyria-inducing activity. Biochem. Pharmacol. 1965; 14: 1077
   PubMed Web of Science ®Google Scholar
• Onisawa J., Labbe R. F. Effects of diethyl-1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxy-late on the metabolism of porphyrins and iron. J. Biol. Chem. 1963; 238: 724
   PubMed Web of Science ®Google Scholar
• Rifkind A. B. Maintenance of microsomal hemoprotein concentration following inhibition of ferrochelatase activity by 3,5-diethoxycarbonyl-l,4-dihydrocollidine in chick embryo liver. J. Biol. Chem. 1979; 254: 4636
   PubMed Web of Science ®Google Scholar
• Tephly T. R., Gibbs A. H., De Matteis F. Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferrolyase. Biochem. J. 1979; 180: 241
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Beilan H. S., Kunze K. L. N-Methylprotoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocol-lidine. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 1490
   PubMed Web of Science ®Google Scholar
• Cole S. P. C., Whitney R. A., Marks G. S. Ferrochelatase inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) and its analogues in chick embryo liver cells. Mol. Pharmacol. 1981; 20: 395
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Beilan H. S., Kunze K. L. N-Alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-l,4-dihydrocollidine-treated rats. J. Biol. Chem. 1981; 256: 6708
   PubMed Web of Science ®Google Scholar
• De Matteis F., Gibbs A. H., Farmer P. B., Lamb J. H. Liver production of N-alkylated porphyrins caused in mice by treatment with substituted dihydropyridines. FEBS Lett. 1981; 129: 328
   PubMed Web of Science ®Google Scholar
• Tephly T. R., Coffman B. L., Ingall G., Abon Zeit-Har G. S., Gogg H. M., Tabba H. D., Smith K. M. Identification of N-methylprotoporphyrin IX in livers of untreated mice and mice treated with 3,5-diethoxycarbonyl-1,4-dihydrocollidine: source of the methyl group. Arch. Biochem. Biophys. 1981; 212: 120
   PubMed Web of Science ®Google Scholar
• De Matteis F., Gibbs A. H. Drug-induced conversion of liver haem into modified porphyrins. Evidence for two classes of products. Biochem. J. 1980; 187: 285
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Correia M. A. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu. Rev. Pharmacol. Toxicol. 1983; 23: 481
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Mathews J. M. Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Isolation of an NN-bridged benzyne-protoporphyrin IX adduct. Biochem. J. 1981; 195: 761
   PubMed Web of Science ®Google Scholar
• Muakkassah S. F., Yang W. C. T. Mechanism of the inhibitory action of phenelzine on microsomal drug metabolism. J. Pharmacol. Exp. Ther. 1981; 219: 147
   PubMed Web of Science ®Google Scholar
• Jonen H. G., Werringloer J., Prough R. A., Estabrook R. W. The reaction of phenylhydra-zine with microsomal cytochrome P-450: catalysis of heme modification. J. Biol. Chem. 1982; 257: 4404
   PubMed Web of Science ®Google Scholar
• Hanzlik R. P., Kishore V., Tullman R. Cyclopropylamines as suicide substrates for cytochrome P-450. J. Med. Chem. 1979; 22: 759
   PubMed Web of Science ®Google Scholar
• Macdonald T. L., Karimullah Z., Burka L. T., Peyman P., Guengerich F. P. Mechanism of cytochrome P-450 inhibition by cyclopropylamines. J. Am. Chem. Soc. 1982; 104: 2050
   Web of Science ®Google Scholar
• Hanzlik R. P., Tullman R. H. Suicidal inactivation of cytochrome P-450 by cyclopropylamines. Evidence for cation-radical intermediates. J. Am. Chem. Soc. 1982; 104: 2048
   Web of Science ®Google Scholar
• De Matteis F. Loss of liver cytochrome P-450 caused by chemicals. Damage to the apoprotein and degradation of the heme moiety. Handbook of Experimental Pharmacology, F. De Matteis, W. N. Aldridge. Springer-Verlag, Berlin 1978; Vol. 44: 95
   Google Scholar
• Ortiz de Montellano P. R., Mico B. A., Yost G. S. Suicidal inactivation of cytochrome P-450. Formation of a heme-substrate covalent adduct. Biochem. Biophys. Res. Commun. 1978; 83: 132
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Mico B. A. Destruction of cytochrome P-450 by ethylene and other olefins. Mol. Pharmacol. 1980; 18: 128
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Beilan H. S., Kunze K. L., Mico B. A. Destruction of cytochrome P-450 by ethylene. Structure of the resulting prosthetic heme adduct. J. Biol. Chem. 1981; 256: 4395
   PubMed Web of Science ®Google Scholar
• De Matteis F., Gibbs A. H., Jackson A. H., Weerasinghe S. Conversion of liver haem into N-substituted porphyrins or green pigments. Nature of the substituent at the pyrrole nitrogen atom. FEBS Lett. 1980; 119: 109
   PubMed Web of Science ®Google Scholar
• White I. N. H., Muller-Eberhard U. Decreased liver cytochrome P-450 in rats caused by no-rethindrone or ethynyloestradiol. Biochem. J. 1977; 166: 57
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Kunze K. L., Yost G. S., Mico B. A. Self-catalyzed destruction of cytochrome P-450: covalent binding of ethynyl sterols to prosthetic heme. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 746
   PubMed Web of Science ®Google Scholar
• White I. N. H. Metabolic activation of acetylenic substituents to derivatives in the rat causing the loss of hepatic cytochrome P-450 and haem. Biochem. J. 1978; 174: 853
   PubMed Web of Science ®Google Scholar
• Skrinjaric-Spoljar M., Matthews H. B., Engel J. L., Casida J. E. Response of hepatic microsomal mixed-function oxidases to various types of insecticide chemical synergists administered to mice. Biochem. Pharmacol. 1971; 20: 1607
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Kunze K. L. Self-catalyzed inactivation of hepatic cytochrome P-450 by ethynyl substrates. J. Biol. Chem. 1980; 255: 5578
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Kunze K. L., Beilan H. S., Wheeler C. Destruction of cytochrome P-450 by vinyl fluoride, fluroxene, and acetylene. Evidence for a radical intermediate in olefin oxidation. Biochemistry 1982; 21: 1331
   PubMed Web of Science ®Google Scholar
• Smith R. P. Toxic responses of the blood. Cassarett and Doull's Toxicology: The Basic Science of Poisons2nd ed., J. Doull, C. D. Klaassen, M. A. Amdur. MacMillan, New York 1980; 311
   Google Scholar
• Kiese M. Methemoglobinemia: A Comprehensive Treatise. CRC Press, Boca Raton, Florida 1974
   Google Scholar
• Doyle M. P., Pickering R. A., da Conceicao J. Structural effects in alkyl nitrite oxidation of human hemoglobin. J. Biol. Chem. 1984; 259: 80
   PubMed Web of Science ®Google Scholar
• Bennett B. M., Nakatsu K., Brien J. F., Marks G. S. Biotransformation of glyceryl trinitrate to glyceryl dinitrate by human hemoglobin. Can. J. Physiol. Pharmacol. 1984; 62: 704
   PubMed Web of Science ®Google Scholar
• Augusto O., Kunze K. L., Ortiz De Montellano P. R. N-Phenylprotoporphyrin IX formation in the hemoglobin-phenylhydrazine reaction: evidence for a protein-stabilized iron-phenyl intermediate. J. Biol. Chem. 1982; 257: 6231
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Kunze K. L., Augusto O. Hemoprotein destruction. Iron-nitrogen shift of a phenyl group in a porphyrin complex. J. Am. Chem. Soc. 1982; 104: 3545
   Web of Science ®Google Scholar
• Saito S., Itano H. A. β-Mesophenylbiliverdin IXα and N-phenylprotoporphyrin IX, products of the reaction of phenylhydrazine with oxyhemoproteins. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 5508
   PubMed Web of Science ®Google Scholar
• Cole S. P. C., Vavasour E. J., Marks G. S. Drug-induced porphyrin biosynthesis. XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-die-thoxycarbonyl-l,4-dihydro-2,4,6-trimethylpyridine, an inhibitor of ferrochelatase. Biochem. Pharmacol. 1979; 28: 3533
   Web of Science ®Google Scholar
• De Matteis F. Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria. Enzyme 1973; 16: 266
   PubMedGoogle Scholar